TAG:
the clinical laboratory
Marketplace Rewards Those Who Get It Right
By R. Lewis Dark | From the Volume VI No. 8 – June 7, 1999 Issue
INTELLIGENCE BRIEFINGS IN THIS ISSUE REVEAL INTERESTING DEVELOPMENTS in our industry. I would agree with our Editor’s assessment that a new cycle of investment in laboratory companies is about to occur. There is also confirmation that laboratories which offer HMOs more than simple lab test data can…
Investors Coming Back To Clinical Lab Industry
By Robert Michel | From the Volume VI No. 8 – June 7, 1999 Issue
CEO SUMMARY: Wall Street money is beginning to flow back into the commercial laboratory industry. This time the beneficiary is Unilab Corporation of Tarzana, California. New York-based Kelso & Company signed an agreement to buy 93% of Unilab’s shares. The common perception among fin…
AmeriPath, Cytyc, Unilab, Naiad
By Robert Michel | From the Volume VI No. 7 – May 17, 1999 Issue
AMERIPATH INKS PACT WITH MEDAPHIS, BUYS FLORIDA PATH PRACTICE Things are busy at AmeriPath, Inc. of Riviera Beach, Florida. The pathology practice management company announced a number of accomplishments. First, it signed an agreement with Medaphis Corporation…
“May 17, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 7 – May 17, 1999 Issue
Maybe the clinical laboratory industry is finally getting its political act together. Last issue of THE DARK REPORT, we noted that the New York State Clinical Laboratory Association (NYSCLA) is working to get the New York Department of Health to issue an opinion as t…
Lab Contracts Priced Below Cost May be Defined as Inducement
By Robert Michel | From the Volume VI No. 6 – April 26, 1999 Issue
PROBABLY THE MOST SERIOUS problem in the lab industry is one of its own making. “Below cost†contracting is a practice where clinical laboratories offer the managed care company a price which is less than its cost to provide the testing. With laboratory overcapacity still abundant in many cities…
Client Service and Sales Fuel Fast Growth at AML
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
CEO SUMMARY: Here’s proof positive that effective management can make a positive difference in the financial performance of clinical labs. Upon taking title to American Medical Laboratories in the spring of 1997, its new owners used an emphasis on “customer-first†service and aggres…
First-Ever National Gathering Of Lab Sales Managers
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
CEO SUMMARY: Here’s a news-making event for the clinical laboratory industry: a first-ever national meeting of the country’s best sales and marketing managers. Scheduled as a new addition to the EXECUTIVE WAR COLLEGE on May 11-13, it’s an unprecedented opportunity for the nation’s…
Quest to Pay $1.27 Billion To Buy SB’s Lab Division
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
CEO SUMMARY: Consolidation is the story of the clinical laboratory industry during the 1990s. The decade will close out with the granddaddy laboratory consolidation of them all! When Quest Diagnostics Incorporated completes its acquisition of SmithKline Beecham Clinical Laboratories later…
“Value Added†Services Essential to Success
By R. Lewis Dark | From the Volume VI No. 2 – February 1, 1999 Issue
ONE ELEMENT COMMON TO SUCCESSFUL LABORATORY ORGANIZATIONS of the future will be the ability to both understand the concept of “value added†services and to offer such services to customers. At its core, value added is an essential business strategy. There are many ways to define “value added.â…
Beckman Coulter Gets New CEO, Stock Gets Analyst Downgrade
By Robert Michel | From the Volume VI No. 2 – February 1, 1999 Issue
AFTER SPENDING MOST OF 1998 digesting its 1997 acquisition of Coulter Corporation, Beckman Coulter, Inc. is ready for new business initiatives in the diagnostics marketplace. Beckman Coulter enters 1999 with a new leader. John P. Wareham, currently President and CEO, will assume the…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized